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Result: There were total of 339 patients: 158 females and 181 males. 
33 of 107 (30.8%) patients with stage IIIB had documented malignant 
PE, while 31 of 232 (13.4%) patients with stage IV had malignant PE 
(p=<0.01). The median survivals for the 4 subgroups of patients: stage 
IIIB without PE, IIIB with PE, IV without PE and IV with PE were 27 
mo, 6 mo, 10 mo and 7 mo respectively. The survival for stage IIIB 
without PE was statistically signiﬁcantly different from the other three 
subgroups (p=<0.0001). Median survival was 10 months for females 
and 7 months for males (p=0.001).
In univariate analysis, age, histology, family history, menopausal status, 
ethnicity, and smoking history were not signiﬁcant independent prog-
nostic factors. 
There were no signiﬁcant relationships between stage and age, gender, 
or histology. Similarly, there were no associations between family his-
tory and age at diagnosis or histology. 
Conclusion: Malignant PE is more commonly seen with IIIB than IV 
NSCLC, and is an independent prognostic discriminant for survival. 
Survivals of patients with PE in both IIIB and IV are similar, and a 
non-signiﬁcant trend suggests a worse prognosis in comparison to pa-
tients with IV without PE. The small sample size may have contributed 
to the lack of statistically signiﬁcant result. Patients with NSCLC and 
malignant PE could be categorized separately in the staging system if 
these results are statistically conﬁrmed by future studies.
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Background: NSCLC predominantly affects patients in their sixth 
and seventh decades of life. It is unclear whether the presentation and 
outcomes are different in the younger (deﬁned as age ≤ 40 years at the 
time of diagnosis) when compared with older patients (age > 40).
Methods: We reviewed the demographic, clinical and pathologic data 
of all patients diagnosed with NSCLC at Washington University School 
of Medicine-Siteman Cancer Center from 1990 to 2005.
Results: 6118 patients with NSCLC were identiﬁed and among them 
6010 were > 40 years and 108 were ≤ 40 years of age at the time of 
diagnosis. The proportion of women in the younger group was 53.7% 
vs. 43.6% in the older group (p = 0.03). The distribution of stages I, 
II, III and IV in the younger group was 14%, 7.5%, 34.6% and 43.9% 
as compared to 28.9%, 7.8%, 29.8% & 33.5% in the older group (p = 
0.006). Adenocarcinoma was the most common histology in the young-
er group compared to the older group (53.7% vs. 38.1%, p<0.001). 
Squamous cell carcinoma was less common in the younger vs. older 
group (15.7% vs. 29.9%, p<0.001). The proportion of younger patients 
diagnosed with brain metastasis at presentation was 18.5% vs. 10% in 
the older patients (p = 0.004). No signiﬁcant differences were detected 
for metastases to the other sites. The 5-year survival was higher in the 
younger group for each stage, but reached statistical signiﬁcance only 
in stage I disease, likely because of the small sample size (see table).
Conclusion: Lung cancer in younger patients is characterized by 
higher proportion of women, adenocarcinoma histology, stage IV dis-
ease, brain metastases at presentation and better overall survival when 
compared to older patients.
Table. Stage speciﬁc 5-year survival
 Age ≤ 40 Age ≤ 40 Age > 40 Age > 40 p value
 N
5 yr survival 
(%)
N
5 yr survival 
(%)
 
Stage I 15 85 1698 45 0.01
Stage II 8 64 469 31 0.20
Stage III 37 20 1789 12 0.13
Stage IV 47 9 2019 2 0.052
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Background: The median age of patients presenting with non-small 
cell lung cancer (NSCLC) is 70 years and the condition is rare in 
younger adults. NSCLC appears to have a different presentation and 
natural history in younger patients. 
Methods: The National Cancer Data Base (NCDB) is a cancer data-
base maintained by the American College of Surgeons. The NCDB data 
is obtained from the cancer programs participating in the Commission 
on Cancer NCDB annual call for data. Permission was obtained from 
the American College of Surgeons to access and analyze the data for 
publication. All patients diagnosed with NSCLC from 1998 to 2004 
were identiﬁed from the NCDB. The gender, race, stage and histology 
data were obtained from the NCDB. The characteristics of patients with 
NSCLC from 16-39 years of age were compared to the entire group. 
Results: A total of 657,982 patients with NSCLC were diagnosed from 
1998-2004. Only about 0.7% (4769) of these patients was under 40. We 
compared the characteristics of NSCLC in younger group to the entire 
cohort (Table). Younger patients were more likely to be women, 52 
% vs 42 % (p<0.001), and more likely to present with distant disease 
(stage 3 & 4) 74 % vs 60 % (p<0.001). Adenocarcinoma was more 
common in younger patients, 46 % vs. 37 %. Squamous cell carcinoma 
was far less common in younger patients, 12 % vs 27 % (p<0.001). 
Conclusions: Patients with NSCLC who are < 40 years old at diagno-
sis are more likely to be women and have adenocarcinoma and far less 
likely to have squamous cell carcinoma. Thus it appears that NSCLC in 
patients <40 years are biologically different.
<40  % All Patients %
Total Number 4769  657982  
Gender 
 Male 2287 48.0 380645 57.9
 Female 2482 52.0 277337 42.1
Race 
 White 3502 73.4 554147 84.2
 Black 715 15.0 68427 10.4
 Asian 194 4.1 10652 1.6
 Other 358 7.5 24756 3.8
Stage 
